Critical Care Medicine · 2000 · 17 citations · 32 references
MedicinePharmacologyMolecular PharmacologyMucosal Drug DeliveryPharmacodynamicsDigestive PhysiologyGastrointestinal AbsorptionGastrointestinal FunctionGastrointestinal PharmacologyHemorrhagic ShockIntestinal Barrier FunctionGut Barrier PermeabilityIntestinal Barrier IntegrityIntestinal Barrier PermeabilityIntestinal Epithelial Barrier FunctionIntestinal Mucosa BarrierMucosal Blood Flow ReductionResuscitation In Gastrointestinal HemorrhageShock Physiology
OBJECTIVE: To determine actions of the prototype adenosine-regulating agent, acadesine (5-amino-1-[beta-D-ribofuranosyl]imidazole-4-carboxamideriboside; AICAR), on intestinal barrier function after hemorrhagic shock and fluid resuscitation, three series of experiments were performed to measure functional (series 1: intestinal permeability and intramural blood flow), structural (series 2: histology), and biochemical (series 3: tissue concentrations of adenine nucleotides and metabolites) changes. DESIGN: Prospective, controlled animal study. SETTING/SUBJECTS: University laboratory; juvenile crossbred pigs of either gender. INTERVENTIONS: Either AICAR or its saline vehicle were intravenously administered 30 mins before 40% hemorrhage. After 1 hr shock, shed blood plus crystalloid was administered for resuscitation. Data were collected for 1 hr thereafter. MEASUREMENTS AND MAIN RESULTS: In series 1, permeability of the ileum was measured by assaying the portal venous concentration of fluorescein-labeled dextran after placement of this tracer in the lumen. In addition, serosal and mucosal blood flow were monitored with laser-Doppler probes. With vehicle, hemorrhage and resuscitation increased the dextran concentration three-fold and decreased blood flow 50% of the baseline values (both p < .05). AICAR attenuated the permeability increase (p < .05) and attenuated mucosa, but not serosal, ischemia (p < .05). Similar effects were observed with a structurally dissimilar compound-- 4-amino-1-(5-amino-5-deoxy-1-beta-D-ribofuranosyl)-3-bromo-pyrazolo [3,4-d] pyrimidine, a specific adenosine kinase inhibitor-as well as continuous intra-arterial infusion of adenosine. In series 2, AICAR ameliorated the mucosal damage caused by shock/resuscitation (p < .05). In series 3, AICAR increased ileal tissue adenine nucleotides and metabolites during the shock period (p < .05). CONCLUSIONS: AICAR attenuated gut permeability changes, increased mucosal perfusion, and increased tissue adenine nucleotides, which is consistent with preserved intestinal barrier function after hemorrhage and fluid resuscitation. In context with previous studies from this laboratory, these results provide further evidence for a role for adenosine as an endogenous anti-inflammatory autacoid after shock and trauma. Further study is needed to determine the therapeutic potential of adenosine-regulating agents in resuscitation fluids.
32
Intestinal Mucosal Lesion in Low-Flow States
Chu-Jeng Chiu · Archives of Surgery · 1970 · 1.8K citations
Life Sciences, Pathology, Physiology +17
R. Jan A. Goris · Archives of Surgery · 1985 · 1.3K citations
Endotoxemia and Bacteremia During Hemorrhagic Shock The Link Between Trauma and Sepsis?
Benjamin F. Rush, Alan Sori, Thomas F. Murphy et al. · Annals of Surgery · 1988 · 391 citations
The Gut Origin Septic States in Blunt Multiple Trauma (ISS = 40) in the ICU
John R. Border, James M. Hassett, JOHN LADUCA et al. · Annals of Surgery · 1987 · 354 citations